National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Dictionary of Cancer Terms
In EnglishEn español
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In EnglishEn español

dornase alfa inhalation solution (DOR-nayz AL-fuh in-huh-LAY-shun suh-LOO-shun)

 A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Dornase alfa inhalation solution contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called Pulmozyme.



Previous Definitions:dolasetron, dolastatin 10, donepezil, dong quai, donor lymphocyte infusion
Next Definitions:dose, dose-dense chemotherapy, dose-dependent, dose-limiting, dose-rate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov